For a small stock, this board is unusually quiet. I bought 400 shares because my spouse works in the substance rehab field and I thought Vivitrol would be a booming product. Too bad they overpriced it. If they lowered the price, they could make it up on volume. Insurance companies want to reduce expenses and in the long run, I think Vivitrol could be cheaper.